Medicare Enrolled
Dr. Mark Bouffard, M.D.
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Palm Desert, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bouffard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bouffard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bouffard
Dr. Mark Bouffard is a pain medicine physician in Palm Desert, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bouffard performed 2,402 Medicare services across 638 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bouffard received a total of $17,026 from 60 pharmaceutical and/or device companies across 570 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (physical medicine & rehabilitation) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bouffard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 36% volume in CA
$17,026 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,402
Medicare services
Top 36% in CA for pain medicine (physical medicine & rehabilitation) physician
638
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~126 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
958 | $98 | $282 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
590 | $1 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
465 | $0 | $10 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
73 | $2 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $131 | $428 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
49 | $97 | $246 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
43 | $140 | $530 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
30 | $223 | $596 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
26 | $51 | $181 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $131 | $379 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
20 | $193 | $761 |
| Contrast injection for shoulder joint imaging A contrast dye is injected into the shoulder joint to enhance imaging studies. This helps visualize the joint structures more clearly during the procedure. |
17 | $152 | $393 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
17 | $100 | $379 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
16 | $506 | $1,866 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
14 | $286 | $789 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,026
Total received (2018-2024)
Avg $2,432/year across 7 years
Top 14% in CA for pain medicine (physical medicine & rehabilitation) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
570
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,095 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$931 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,156
2023
$1,755
2022
$1,668
2021
$5,025
2020
$2,162
2019
$2,641
2018
$2,618
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$229
ABBVIE INC.
$196
SI-BONE, INC.
$184
PAINTEQ LLC
$162
Lundbeck LLC
$117
Collegium Pharmaceutical, Inc.
$110
Fidia Pharma USA Inc.
$53
Abbott Laboratories
$34
Azurity Pharmaceuticals, Inc.
$23
Avanos Medical
$19
Curonix LLC
$15
PFIZER INC.
$15
Top 3 companies account for 52.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$2,668
BOSTON SCIENTIFIC CORPORATION
$1,793
Abbott Laboratories
$1,293
Collegium Pharmaceutical, Inc.
$1,010
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$910
BioDelivery Sciences International, Inc.
$811
Nevro Corp.
$590
Medtronic USA, Inc.
$550
Daiichi Sankyo Inc.
$489
ABBVIE INC.
$464
Curonix LLC
$432
SI-BONE, INC.
$419
AbbVie Inc.
$398
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$318
Amgen Inc.
$307
PAINTEQ LLC
$301
SPR Therapeutics, Inc
$234
Lilly USA, LLC
$220
Medtronic, Inc.
$219
Horizon Therapeutics plc
$176
Kaleo, Inc.
$173
Biohaven Pharmaceuticals, Inc.
$171
Horizon Pharma plc
$171
Lundbeck LLC
$170
Assertio Therapeutics, Inc.
$163
Biohaven Pharmaceutical Holding Company Ltd.
$150
Takeda Pharmaceuticals U.S.A., Inc.
$149
INSYS Therapeutics Inc
$140
Purdue Pharma L.P.
$139
ARBOR PHARMACEUTICALS, INC.
$137
IDORSIA PHARMACEUTICALS US INC
$129
Scilex Pharmaceuticals Inc.
$129
UPSHER-SMITH LABORATORIES LLC
$126
Teva Pharmaceuticals USA, Inc.
$122
West Therapeutics Development, LLC
$121
SI-BONE, Inc.
$119
Axonics, Inc.
$107
FIDIA PHARMA USA INC.
$104
Shionogi Inc
$86
PFIZER INC.
$86
IBSA Pharma Inc.
$72
AstraZeneca Pharmaceuticals LP
$60
Arbor Pharmaceuticals, Inc.
$55
Almatica Pharma LLC
$55
Novartis Pharmaceuticals Corporation
$53
Fidia Pharma USA Inc.
$53
Allergan, Inc.
$49
SCILEX PHARMACEUTICALS INC.
$46
Avanos Medical
$39
Kowa Pharmaceuticals America, Inc.
$34
Zimmer Biomet Holdings, Inc.
$29
Virtus Pharmaceuticals LLC
$27
Sun Pharmaceutical Industries Inc.
$25
Vanda Pharmaceuticals Inc.
$24
Azurity Pharmaceuticals, Inc.
$23
Hikma Pharmaceuticals USA
$21
Upsher-Smith Laboratories LLC
$21
Stimwave Technologies Incorporated
$20
Pernix Therapeutics Holdings, Inc.
$14
Vertiflex, Inc.
$13
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · Amitiza · Axium INS DRG IPG · Axonics · BELBUCA · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · CAMBIA · CFNS StimQ Peripheral Nerve StimulatorSystem · COOLIEF* COOLED RADIOFREQUENCY · COVEREDGE · Cambia · DRIZALMA SPRINKLE · DUEXIS · EMGALITY · EVENITY · EVZIO · Edarbi · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · General - Pain Management · Gralise · HETLIOZ · HORIZANT · HYMOVIS · Horizant · Hymovis · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Kloxxado · LEVORPHANOL TARTRATE · LYRICA · Lazanda · Licart · MOVANTIK · Morphabond ER · NAPRELAN · NURTEC ODT · Neuromodulation Dspsbls and Accs · OCTRODE · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIMARY CARE - DISEASE STATE · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RESTORE · REYVOW · SPECTRA WAVEWRITER · SPRINT PNS System · SYMPROIC · SYNDROS · Seglentis · Senza · Senza Spinal Cord Stimulation System · Sports Medicine Product Portfolio · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · UBRELVY · VERTIFLEX SUPERION · VIMOVO · VYEPTI · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZAVZPRET · ZEMBRACE SYMTOUCH · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicine physicians within 10 mi
3
Per 100K population
0.1
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bouffard is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bouffard experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bouffard performed 958 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bouffard receive payments from pharmaceutical companies?
Yes. Dr. Bouffard received a total of $17,026 from 60 companies across 570 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bouffard's costs compare to other pain medicine physicians in Palm Desert?
Dr. Bouffard's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bouffard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in Palm Desert
Browse pain medicine physicians in Palm Desert ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in CA
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in CA
Which CA pain medicine physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology